HealthStream, Inc. Reports Strong First Quarter 2026 Results

Key Financial Highlights

• Net Income: HealthStream reported net income of \$5.9 million for Q1 2026, representing a robust 36.4% increase from \$4.3 million in the first quarter of 2025.
• Earnings Per Share (EPS): Diluted EPS rose to \$0.20 per share in Q1 2026, up from \$0.14 per share in Q1 2025—a significant year-over-year improvement.
• Revenues: Net revenues for the quarter reached \$81.2 million, up from \$73.5 million in the prior year’s quarter, indicating strong top-line growth.
• Adjusted EBITDA: The company reaffirmed its 2026 guidance for adjusted EBITDA in the range of \$73 million to \$77 million, underscoring confidence in ongoing operational performance.

Shareholder Actions & Dividend Announcement

• Quarterly Cash Dividend: The Board of Directors declared a quarterly cash dividend of \$0.035 per share of common stock, payable on May 29, 2026 to holders of record as of May 18, 2026. This consistent dividend underscores HealthStream’s commitment to shareholder returns.
• Share Repurchase Program: On March 13, 2026, HealthStream authorized a share repurchase program to buy back up to \$10.0 million of outstanding shares of common stock. Repurchase programs can positively impact share value by reducing the float and signaling management’s confidence in the company’s prospects.

Financial Condition & Balance Sheet Highlights

• Total Shareholders’ Equity: As of March 31, 2026, HealthStream’s shareholders’ equity stood at \$351.99 million, up from \$347.02 million at year-end, reflecting growing net assets.
• Retained Earnings: Retained earnings increased to \$128.47 million from \$123.59 million at December 31, 2025, indicating profitability and prudent financial management.
• Common Stock: The value of common stock on the balance sheet was \$225.09 million as of March 31, 2026, compared to \$231.80 million at year-end, likely reflecting repurchase activity or other capital management actions.
• Marketable Securities & Cash: Marketable securities totaled \$17.79 million, and cash and equivalents amounted to \$36.16 million as of quarter-end, providing liquidity for operations, dividends, and repurchases.

Cash Flow and Capital Allocation

• Net Cash Used in Investing Activities: HealthStream used \$6.32 million in investing activities in Q1 2026, compared to \$7.25 million in Q1 2025. This included acquisitions, purchases of property and equipment, and investments.
• Dividend Payments: Cash dividends paid totaled \$1.03 million in Q1 2026, compared to \$943,000 in Q1 2025.
• No Significant Repurchase Activity YTD: While the \$10 million repurchase program was authorized, no material repurchases appear to have occurred in Q1 2026.

Guidance for Full Year 2026

HealthStream reaffirmed its previously announced full-year 2026 financial guidance:

• Net Income: Target range of \$20.4 million to \$22.8 million
• Adjusted EBITDA: Target range of \$73 million to \$77 million

This guidance assumes stable economic conditions and does not include the impact of potential acquisitions, divestitures, or gains/losses from changes in fair value of investments.

Other Notable Items & Forward-Looking Statements

• HealthStream’s platform continues to integrate AI technologies, positioning the company for future growth in healthcare workforce development solutions.
• A conference call with senior management is scheduled for May 5, 2026 to discuss results and outlook, accessible via webcast and telephone.
• The company remains in compliance with all SEC filing requirements and is not classified as an emerging growth company.

Potential Price-Sensitive Information for Investors

• Strong Earnings Growth: The substantial growth in net income and EPS may positively impact investor sentiment and share price.
• Dividend Declaration: The ongoing commitment to quarterly dividends is a positive for income-focused investors.
• Share Repurchase Authorization: The \$10 million buyback program, if executed, could reduce the share count and support share value.
• Reaffirmed Guidance: Management’s confidence in the full-year outlook may influence market expectations for future results.

Disclaimer

This article includes certain forward-looking statements regarding HealthStream’s financial performance and dividend policy for 2026. Actual results may differ materially due to risks and uncertainties, including economic conditions, industry developments, and legal/regulatory factors. Investors should review the company’s official filings, including the Form 10-K for the year ended December 31, 2025, and other SEC filings for more information. HealthStream undertakes no obligation to update or revise any forward-looking statements. This article is intended for informational purposes only and does not constitute investment advice.

View HEALTHSTREAM INC Historical chart here